List view / Grid view
26 November 2015 | By Victoria White
Researchers from the University of Basel have, for the first time, successfully combined an antibody-drug conjugate with a therapy that stimulates the immune system to attack breast cancer cells...
26 November 2015 | By Victoria White
Venom Knowledge Base summarises the results of 5,117 studies in the medical literature describing the use of venom toxins as painkillers and as treatments for diseases...
26 November 2015 | By Victoria White
Scientists from the University of Toronto have switched off, one by one, almost 18,000 genes - 90% of the entire human genome - to find the genes that are essential for cell survival...
25 November 2015 | By Victoria White
The transaction, expected to complete next month, is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services...
25 November 2015 | By Victoria White
Rugen has already demonstrated efficacy for its compounds in animal models of ASD and OCD...
25 November 2015 | By
Ablynx and Novo Nordisk hope to discover and develop novel multi-specific drug candidates using Ablynx's proprietary Nanobody technology...
25 November 2015 | By Victoria White
The companies have entered an agreement to discover and develop novel, small-molecule CGRP antagonists for the treatment of migraine...
24 November 2015 | By Victoria White
Pneumolysin is associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia...
24 November 2015 | By Kate Douetil
UCL has announced the formation of Athena Vision, a biopharmaceutical company focused on developing gene therapies for eye diseases...
24 November 2015 | By Victoria White
The companies have said they will focus is on immuno-oncology, one of the hottest and most dynamic areas in biotechnology...
23 November 2015 | By Victoria White
Scientists have shown how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola...
23 November 2015 | By Victoria White
Using bone samples from people undergoing hip replacement surgery, researchers were able to show that a drug that activates the Wnt pathway causes stem cells found within bones to divide and to turn into more bone cells...
23 November 2015 | By Victoria White
The Ross Fund includes £115 million to develop new drugs, diagnostics and insecticides for malaria, TB and other infectious disease resistance...
23 November 2015 | By Victoria White
Evgen has said it will use its Sulforadex platform to synthesise and stabilise the newly acquired compounds with a view to taking the most promising into clinical development...
23 November 2015 | By Victoria White
Cobra will be using its cell line development service, maxXpress, to produce the growth hormone antagonist fusion protein...
